Multi-billion-dollar deals at JPM Week augur a busy BIO CEO 2025
U.S. biotech generates $3.2 trillion in a year, report shows
Insurers and Middlemen Force Many of the Sickest Patients to Face High Out-of-Pocket Costs
CEO to Feature: Reshma Kewalramani (CEO of Vertex Pharmaceuticals) – Leading advancements in biotechnology and industrial health innovations.